VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42893766 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000318.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q42893766‏
024 ‎‡a 0000-0001-7312-8011‏ ‎‡2 orcid‏
024 ‎‡a 35499758300‏ ‎‡2 scopus‏
024 ‎‡a 57199984868‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q42893766‏
100 0 ‎‡a Alfredo Costa‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Alfredo Costa‏ ‎‡c Italian neurologist‏ ‎‡9 en‏
400 0 ‎‡a Alfredo Costa‏ ‎‡c neurólogo italiano‏ ‎‡9 es‏
400 0 ‎‡a Alfredo Costa‏ ‎‡c neurologo italiano‏ ‎‡9 it‏
400 0 ‎‡a Alfredo Costa‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Альфредо Коста‏ ‎‡9 ru‏
670 ‎‡a Author's A case of Wernicke encephalopathy combined with disulfiram intoxication‏
670 ‎‡a Author's A novel ATP1A2 mutation in a family with FHM type II‏
670 ‎‡a Author's Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators‏
670 ‎‡a Author's Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant‏
670 ‎‡a Author's Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement‏
670 ‎‡a Author's Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients‏
670 ‎‡a Author's An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics‏
670 ‎‡a Author's Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G.‏
670 ‎‡a Author's Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance‏
670 ‎‡a Author's Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.‏
670 ‎‡a Author's Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia‏
670 ‎‡a Author's Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis‏
670 ‎‡a Author's Cognitive impairment in depression: recent advances and novel treatments.‏
670 ‎‡a Author's Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease‏
670 ‎‡a Author's Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly‏
670 ‎‡a Author's Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants‏
670 ‎‡a Author's Early cortical and late striatal diffusion restriction on 3T MRI in a long-lived sporadic creutzfeldt-jakob disease case‏
670 ‎‡a Author's Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers‏
670 ‎‡a Author's Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients‏
670 ‎‡a Author's Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers‏
670 ‎‡a Author's Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.‏
670 ‎‡a Author's Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats‏
670 ‎‡a Author's Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors‏
670 ‎‡a Author's Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide‏
670 ‎‡a Author's Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?‏
670 ‎‡a Author's Enzyme replacement therapy in late-onset type II glycogenosis.‏
670 ‎‡a Author's Enzyme replacement therapy in severe adult-onset glycogen storage disease type II‏
670 ‎‡a Author's Erectile dysfunction as a sentinel symptom of cardiovascular autonomic neuropathy in heavy drinkers‏
670 ‎‡a Author's Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat.‏
670 ‎‡a Author's Expression of chemokine receptors in the rat brain‏
670 ‎‡a Author's Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2‏
670 ‎‡a Author's Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders‏
670 ‎‡a Author's Free plasma catecholamine levels in healthy subjects: a basal and dynamic study. The influence of age.‏
670 ‎‡a Author's Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum‏
670 ‎‡a Author's Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease‏
670 ‎‡a Author's Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1‏
670 ‎‡a Author's Immune-mediated neuropathies in myeloma patients treated with bortezomib‏
670 ‎‡a Author's Impact of Medical Care on Symptomatic Drug Consumption and Quality of Life in Headache: A One-Year Population Study‏
670 ‎‡a Author's Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease‏
670 ‎‡a Author's Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro‏
670 ‎‡a Author's Interleukin-induced vasopressin release is inhibited by L-arginine‏
670 ‎‡a Author's Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency‏
670 ‎‡a Author's Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients‏
670 ‎‡a Author's Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 Alpha and lack of effe‏
670 ‎‡a Author's Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II‏
670 ‎‡a Author's Medial temporal lobe atrophy and posterior atrophy scales normative values‏
670 ‎‡a Author's Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro‏
670 ‎‡a Author's Migraine and psychiatric comorbidity: a review of clinical findings‏
670 ‎‡a Author's Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.‏
670 ‎‡a Author's Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders‏
670 ‎‡a Author's Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro‏
670 ‎‡a Author's Nitric oxide modulates the release of vasopressin from rat hypothalamic explants‏
670 ‎‡a Author's Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels‏
670 ‎‡a Author's Nitroglycerin-induced activation of monoaminergic transmission in the rat.‏
670 ‎‡a Author's O061. Frontal thermography in healthy individuals and headache patients: reliability of the method‏
670 ‎‡a Author's Opposite effects of l-arginine and nitroglycerin on cerebral blood velocity: Nitric oxide precursors and cerebral blood velocity‏
670 ‎‡a Author's P033. Headache and commuting: preliminary data in a group of workers‏
670 ‎‡a Author's Parenteral indomethacin‏
670 ‎‡a Author's Parenteral indomethacin (the INDOTEST) in cluster headache‏
670 ‎‡a Author's Recent advances in migraine therapy‏
670 ‎‡a Author's Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy‏
670 ‎‡a Author's Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).‏
670 ‎‡a Author's Role of Cerebrospinal Fluid Biomarkers and‏
670 ‎‡a Author's Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.‏
670 ‎‡a Author's Septo-optic dysplasia and psychiatric disorders: a case report‏
670 ‎‡a Author's Specific Patterns of White Matter Alterations Help Distinguishing Alzheimer's and Vascular Dementia.‏
670 ‎‡a Author's Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide‏
670 ‎‡a Author's Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.‏
670 ‎‡a Author's The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease‏
670 ‎‡a Author's The brain as a target for adrenocortical steroids: cognitive implications‏
670 ‎‡a Author's The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.‏
670 ‎‡a Author's The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache‏
670 ‎‡a Author's The influence of gender in the evaluation of platelet and plasma catecholamines‏
670 ‎‡a Author's The mitochondrial DNA A3243G mutation in Portugal: clinical and molecular studies in 5 families.‏
670 ‎‡a Author's The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias‏
670 ‎‡a Author's The Treatment of Trigeminal Autonomic Cephalalgias: An Overview‏
670 ‎‡a Author's Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients.‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/ICCU|256‏
909 ‎‡a (orcid) 0000000173128011‏ ‎‡9 1‏
909 ‎‡a (scopus) 35499758300‏ ‎‡9 1‏
909 ‎‡a (scopus) 57199984868‏ ‎‡9 1‏
919 ‎‡a effectofgrowthhormonesecretagoguesandneuropeptideyonhypothalamichormonereleasefromacuterathypothalamicexplants‏ ‎‡A The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.‏ ‎‡9 1‏
919 ‎‡a neuropharmacologyofclusterheadacheandothertrigeminalautonomiccephalalgias‏ ‎‡A The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias‏ ‎‡9 1‏
919 ‎‡a stimulatingeffectofhiv1coatproteingp120oncorticotropinreleasinghormoneandargininevasopressinintherathypothalamusinvolvementofnitricoxide‏ ‎‡A Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide‏ ‎‡9 1‏
919 ‎‡a o061frontalthermographyinhealthyindividualsandheadachepatientsreliabilityofthemethod‏ ‎‡A O061. Frontal thermography in healthy individuals and headache patients: reliability of the method‏ ‎‡9 1‏
919 ‎‡a parenteralindomethacintheindotestinclusterheadache‏ ‎‡A Parenteral indomethacin (the INDOTEST) in cluster headache‏ ‎‡9 1‏
919 ‎‡a nitricoxidemodulatesthereleaseofcorticotropinreleasinghormonefromtherathypothalamusinvitro‏ ‎‡A Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro‏ ‎‡9 1‏
919 ‎‡a incrementalvalueofamyloidpetversuscsfinthediagnosisofalzheimersdisease‏ ‎‡A Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a leukocytederivedmicrovesiclesasdiseaseprogressionbiomarkersinslowprogressingamyotrophiclateralsclerosispatients‏ ‎‡A Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients‏ ‎‡9 1‏
919 ‎‡a galaninandαmshautoantibodiesincerebrospinalfluidofpatientswithalzheimersdisease‏ ‎‡A Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a endothelin1stimulatestheinvitroreleaseofneurohypophysealhormonesbutnotcorticotropinreleasinghormoneviaetareceptors‏ ‎‡A Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors‏ ‎‡9 1‏
919 ‎‡a enzymereplacementtherapyinsevereadultonsetglycogenstoragediseasetype2‏ ‎‡A Enzyme replacement therapy in severe adult-onset glycogen storage disease type II‏ ‎‡9 1‏
919 ‎‡a effectofeveningbromazepamadministrationonbloodpressureandheartrateinmildhypertensivepatients‏ ‎‡A Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients‏ ‎‡9 1‏
919 ‎‡a assessmentofhypothalamopituitaryadrenalaxisfunctioninginnondepressedearlyabstinentalcoholics‏ ‎‡A An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics‏ ‎‡9 1‏
919 ‎‡a acuteandsubacuteeffectsofendotoxinonhypothalamicgaseousneuromodulators‏ ‎‡A Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators‏ ‎‡9 1‏
919 ‎‡a caseofwernickeencephalopathycombinedwithdisulfiramintoxication‏ ‎‡A A case of Wernicke encephalopathy combined with disulfiram intoxication‏ ‎‡9 1‏
919 ‎‡a novelatp1a2mutationinafamilywithfhmtype2‏ ‎‡A A novel ATP1A2 mutation in a family with FHM type II‏ ‎‡9 1‏
919 ‎‡a adultonsetalexanderdiseaseassociatedwithamutationinanalternativegfaptranscriptmaybephenotypicallymodulatedbyanonneutralhdac6variant‏ ‎‡A Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant‏ ‎‡9 1‏
919 ‎‡a alzheimersparkinsonsdiseaseandamyotrophiclateralsclerosisgeneexpressionpatternsdivergencerevealsdifferentgradeofrnametabolisminvolvement‏ ‎‡A Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement‏ ‎‡9 1‏
919 ‎‡a ambulatory24hecgmonitoringandcardiovascularautonomicassessmentforthescreeningofsilentmyocardialischemiainelderlytype2diabetichypertensivepatients‏ ‎‡A Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients‏ ‎‡9 1‏
919 ‎‡a apoptosisinducedbygp120intheneocortexofratinvolvesenhancedexpressionofcyclooxygenasetype2andispreventedbynmdareceptorantagonistsandbythe21aminosteroidu74389g‏ ‎‡A Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G.‏ ‎‡9 1‏
919 ‎‡a assessingtherelativeincidenceofmitochondrialdnaa3243ginmigrainewithoutaurawithmaternalinheritance‏ ‎‡A Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance‏ ‎‡9 1‏
919 ‎‡a cerebrospinalfluidcorticotropinreleasingfactorlevelsandstimulationtestindementiaofthealzheimertype‏ ‎‡A Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.‏ ‎‡9 1‏
919 ‎‡a cerebrospinalfluidlevelsoftauphosphorylatedatthreonine181inpatientswithalzheimersdiseaseandvasculardementia‏ ‎‡A Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia‏ ‎‡9 1‏
919 ‎‡a changesinnutritionalstatusandbodycompositionduringenzymereplacementtherapyinadultonsettype2glycogenosis‏ ‎‡A Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentindepressionrecentadvancesandnoveltreatments‏ ‎‡A Cognitive impairment in depression: recent advances and novel treatments.‏ ‎‡9 1‏
919 ‎‡a curcuminandnovelsyntheticanalogsincellbasedstudiesofalzheimersdisease‏ ‎‡A Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a diazepamasanoralhypnoticincreasesnocturnalbloodpressureintheelderly‏ ‎‡A Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly‏ ‎‡9 1‏
919 ‎‡a differentialeffectsofneuroexcitatoryaminoacidsoncorticotropinreleasinghormone41andvasopressinreleasefromrathypothalamicexplants‏ ‎‡A Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants‏ ‎‡9 1‏
919 ‎‡a earlycorticalandlatestriataldiffusionrestrictionon3tmriinalonglivedsporadiccreutzfeldtjakobdiseasecase‏ ‎‡A Early cortical and late striatal diffusion restriction on 3T MRI in a long-lived sporadic creutzfeldt-jakob disease case‏ ‎‡9 1‏
919 ‎‡a effectofdiazepamon24hourbloodpressureandheartrateinhealthyyoungvolunteers‏ ‎‡A Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers‏ ‎‡9 1‏
919 ‎‡a effectofflunitrazepamasanoralhypnoticon24hourbloodpressureinhealthyvolunteers‏ ‎‡A Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers‏ ‎‡9 1‏
919 ‎‡a effectoframiprilhydrochlorothiazideandramiprilcanrenonecombinationonatrialfibrillationrecurrenceinhypertensivetype2diabeticpatientswithandwithoutcardiacautonomicneuropathy‏ ‎‡A Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.‏ ‎‡9 1‏
919 ‎‡a effectsofacuteandchronicrestraintstressonnitroglycerininducedhyperalgesiainrats‏ ‎‡A Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats‏ ‎‡9 1‏
919 ‎‡a endotoxinstimulatesanendogenouspathwayregulatingcorticotropinreleasinghormoneandvasopressinreleaseinvolvingthegenerationofnitricoxideandcarbonmonoxide‏ ‎‡A Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide‏ ‎‡9 1‏
919 ‎‡a enzymereplacementtherapyinadultonsetglycogenosis2isquantitativemusclemrihelpful‏ ‎‡A Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?‏ ‎‡9 1‏
919 ‎‡a enzymereplacementtherapyinlateonsettype2glycogenosis‏ ‎‡A Enzyme replacement therapy in late-onset type II glycogenosis.‏ ‎‡9 1‏
919 ‎‡a erectiledysfunctionasasentinelsymptomofcardiovascularautonomicneuropathyinheavydrinkers‏ ‎‡A Erectile dysfunction as a sentinel symptom of cardiovascular autonomic neuropathy in heavy drinkers‏ ‎‡9 1‏
919 ‎‡a estradiolreducescytochrome100translocationandminimizeshippocampaldamagecausedbytransientglobalischemiainrat‏ ‎‡A Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat.‏ ‎‡9 1‏
919 ‎‡a expressionofchemokinereceptorsintheratbrain‏ ‎‡A Expression of chemokine receptors in the rat brain‏ ‎‡9 1‏
919 ‎‡a familialhemiplegicmigrainetype2duetoanovelmissensemutationinatp1a2‏ ‎‡A Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2‏ ‎‡9 1‏
919 ‎‡a familybasedassociationstudyof5httlprtphmaoaanddrd4polymorphismsinmooddisorders‏ ‎‡A Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders‏ ‎‡9 1‏
919 ‎‡a freeplasmacatecholaminelevelsinhealthysubjectsabasalanddynamicstudytheinfluenceofage‏ ‎‡A Free plasma catecholamine levels in healthy subjects: a basal and dynamic study. The influence of age.‏ ‎‡9 1‏
919 ‎‡a frontalandcerebellaratrophysupportsftsdalsclinicalcontinuum‏ ‎‡A Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum‏ ‎‡9 1‏
919 ‎‡a glialandneuronalcellsexpressfunctionalchemokinereceptorcxcr4anditsnaturalligandstromalcellderivedfactor1‏ ‎‡A Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1‏ ‎‡9 1‏
919 ‎‡a immunemediatedneuropathiesinmyelomapatientstreatedwithbortezomib‏ ‎‡A Immune-mediated neuropathies in myeloma patients treated with bortezomib‏ ‎‡9 1‏
919 ‎‡a impactofmedicalcareonsymptomaticdrugconsumptionandqualityoflifeinheadachea1yearpopulationstudy‏ ‎‡A Impact of Medical Care on Symptomatic Drug Consumption and Quality of Life in Headache: A One-Year Population Study‏ ‎‡9 1‏
919 ‎‡a interleukin1betaandinterleukin6stimulateneurohypophysialhormonereleaseinvitro‏ ‎‡A Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro‏ ‎‡9 1‏
919 ‎‡a interleukininducedvasopressinreleaseisinhibitedby50arginine‏ ‎‡A Interleukin-induced vasopressin release is inhibited by L-arginine‏ ‎‡9 1‏
919 ‎‡a lethaldilatedcardiomyopathyduetolongchain3hydroxyacylcoadehydrogenasedeficiency‏ ‎‡A Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency‏ ‎‡9 1‏
919 ‎‡a lipopolysaccharidemodulationofeicosanoidandcorticotrophinreleasinghormonereleasefromrathypothalamicexplantsandastrocyteculturesinvitroevidencefortheinvolvementofprostaglandine2butnotprostaglandinf2 Alpha andlackofeffe‏ ‎‡A Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 Alpha and lack of effe‏ ‎‡9 1‏
919 ‎‡a longtermobservationalnonrandomizedstudyofenzymereplacementtherapyinlateonsetglycogenosistype2‏ ‎‡A Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II‏ ‎‡9 1‏
919 ‎‡a medialtemporallobeatrophyandposterioratrophyscalesnormativevalues‏ ‎‡A Medial temporal lobe atrophy and posterior atrophy scales normative values‏ ‎‡9 1‏
919 ‎‡a melatoninanditsanalogsinhibitthebasalandstimulatedreleaseofhypothalamicvasopressinandoxytocininvitro‏ ‎‡A Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro‏ ‎‡9 1‏
919 ‎‡a migraineandpsychiatriccomorbidityareviewofclinicalfindings‏ ‎‡A Migraine and psychiatric comorbidity: a review of clinical findings‏ ‎‡9 1‏
919 ‎‡a migrainewithoutauraandreproductivelifeeventsaclinicalepidemiologicalstudyin1300women‏ ‎‡A Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.‏ ‎‡9 1‏
919 ‎‡a multicentreitalianfamilybasedassociationstudyontyrosinehydroxylasecatecholomethyltransferaseandwolframsyndrome1polymorphismsinmooddisorders‏ ‎‡A Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders‏ ‎‡9 1‏
919 ‎‡a nitricoxidemodulatesthereleaseofvasopressinfromrathypothalamicexplants‏ ‎‡A Nitric oxide modulates the release of vasopressin from rat hypothalamic explants‏ ‎‡9 1‏
919 ‎‡a nitricoxidepathwayandresponsetonitroglycerininclusterheadachepatientsplasmanitriteandcitrullinelevels‏ ‎‡A Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels‏ ‎‡9 1‏
919 ‎‡a nitroglycerininducedactivationofmonoaminergictransmissionintherat‏ ‎‡A Nitroglycerin-induced activation of monoaminergic transmission in the rat.‏ ‎‡9 1‏
919 ‎‡a oppositeeffectsof50arginineandnitroglycerinoncerebralbloodvelocitynitricoxideprecursorsandcerebralbloodvelocity‏ ‎‡A Opposite effects of l-arginine and nitroglycerin on cerebral blood velocity: Nitric oxide precursors and cerebral blood velocity‏ ‎‡9 1‏
919 ‎‡a p033headacheandcommutingpreliminarydatainagroupofworkers‏ ‎‡A P033. Headache and commuting: preliminary data in a group of workers‏ ‎‡9 1‏
919 ‎‡a parenteralindomethacin‏ ‎‡A Parenteral indomethacin‏ ‎‡9 1‏
919 ‎‡a recentadvancesinmigrainetherapy‏ ‎‡A Recent advances in migraine therapy‏ ‎‡9 1‏
919 ‎‡a retinalmigraineasunusualfeatureofcerebralautosomaldominantarteriopathywithsubcorticalinfarctsandleukoencephalopathy‏ ‎‡A Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy‏ ‎‡9 1‏
919 ‎‡a retinalmigraineasunusualfeatureofcerebralautosomaldominantarteriopathywithsubcorticalinfarctsandleukoencephalopathycadasil‏ ‎‡A Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).‏ ‎‡9 1‏
919 ‎‡a roleofcerebrospinalfluidbiomarkersand‏ ‎‡A Role of Cerebrospinal Fluid Biomarkers and‏ ‎‡9 1‏
919 ‎‡a roleofcerebrospinalfluidbiomarkersand18fflorbetapirpetimaginginthediagnosisofprimaryprogressiveaphasiaaretrospectiveanalysis‏ ‎‡A Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.‏ ‎‡9 1‏
919 ‎‡a septoopticdysplasiaandpsychiatricdisordersacasereport‏ ‎‡A Septo-optic dysplasia and psychiatric disorders: a case report‏ ‎‡9 1‏
919 ‎‡a specificpatternsofwhitematteralterationshelpdistinguishingalzheimersandvasculardementia‏ ‎‡A Specific Patterns of White Matter Alterations Help Distinguishing Alzheimer's and Vascular Dementia.‏ ‎‡9 1‏
919 ‎‡a stimulationofcorticotrophinreleasinghormonereleasebytheobeseobgeneproductleptinfromhypothalamicexplants‏ ‎‡A Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.‏ ‎‡9 1‏
919 ‎‡a angiotensinconvertingenzymeinsertiondeletionpolymorphismmodifiestheclinicaloutcomeinpatientswithpompedisease‏ ‎‡A The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease‏ ‎‡9 1‏
919 ‎‡a brainasatargetforadrenocorticalsteroidscognitiveimplications‏ ‎‡A The brain as a target for adrenocortical steroids: cognitive implications‏ ‎‡9 1‏
919 ‎‡a effectofintranasalcocaineandlidocaineonnitroglycerininducedattacksinclusterheadache‏ ‎‡A The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache‏ ‎‡9 1‏
919 ‎‡a influenceofgenderintheevaluationofplateletandplasmacatecholamines‏ ‎‡A The influence of gender in the evaluation of platelet and plasma catecholamines‏ ‎‡9 1‏
919 ‎‡a mitochondrialdnaa3243gmutationinportugalclinicalandmolecularstudiesin5families‏ ‎‡A The mitochondrial DNA A3243G mutation in Portugal: clinical and molecular studies in 5 families.‏ ‎‡9 1‏
919 ‎‡a treatmentoftrigeminalautonomiccephalalgiasanoverview‏ ‎‡A The Treatment of Trigeminal Autonomic Cephalalgias: An Overview‏ ‎‡9 1‏
919 ‎‡a 204hourbloodpressureprofileorthostatichypotensionandcardiacdysautonomiainelderlytype2diabetichypertensivepatients‏ ‎‡A Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BLBNB|000167019‏
996 ‎‡2 LC|n 88235328‏
996 ‎‡2 ISNI|0000000068813252‏
996 ‎‡2 LC|n 98111481‏
996 ‎‡2 NUKAT|n 2005083414‏
996 ‎‡2 BLBNB|000167012‏
996 ‎‡2 PTBNP|1846920‏
996 ‎‡2 BLBNB|000167017‏
996 ‎‡2 PTBNP|90207‏
996 ‎‡2 NSK|000164874‏
996 ‎‡2 LC|no2018026723‏
996 ‎‡2 ISNI|0000000033431780‏
996 ‎‡2 BLBNB|000166981‏
996 ‎‡2 BLBNB|000166983‏
996 ‎‡2 ISNI|0000000067656427‏
996 ‎‡2 PTBNP|158242‏
996 ‎‡2 PTBNP|175886‏
996 ‎‡2 PTBNP|1191503‏
996 ‎‡2 LC|n 90616108‏
996 ‎‡2 PTBNP|87169‏
996 ‎‡2 ISNI|0000000069084696‏
996 ‎‡2 ISNI|0000000070198682‏
996 ‎‡2 PTBNP|238113‏
996 ‎‡2 ISNI|000000004295919X‏
996 ‎‡2 PTBNP|169354‏
996 ‎‡2 LC|nb2019017414‏
996 ‎‡2 PTBNP|1089555‏
996 ‎‡2 ISNI|0000000069926259‏
996 ‎‡2 ISNI|0000000069007957‏
996 ‎‡2 BLBNB|000167015‏
996 ‎‡2 PTBNP|165825‏
996 ‎‡2 PTBNP|1382900‏
996 ‎‡2 BNC|981058609173106706‏
996 ‎‡2 ISNI|000000006992750X‏
996 ‎‡2 DNB|1219312630‏
996 ‎‡2 SUDOC|154220590‏
996 ‎‡2 PTBNP|1307348‏
996 ‎‡2 SUDOC|074734636‏
996 ‎‡2 PTBNP|1389585‏
996 ‎‡2 ISNI|0000000068901324‏
996 ‎‡2 J9U|987007344280905171‏
996 ‎‡2 PTBNP|1888064‏
996 ‎‡2 PTBNP|152644‏
996 ‎‡2 SUDOC|250665573‏
996 ‎‡2 BIBSYS|90858882‏
996 ‎‡2 DNB|1144991692‏
996 ‎‡2 ISNI|0000000068396460‏
996 ‎‡2 ISNI|0000000068497755‏
996 ‎‡2 PTBNP|227774‏
996 ‎‡2 ISNI|0000000070331498‏
996 ‎‡2 ISNI|000000004820429X‏
996 ‎‡2 LIH|LNB:C_y__v_U;=CX‏
996 ‎‡2 PTBNP|116796‏
996 ‎‡2 ISNI|0000000068008907‏
996 ‎‡2 PTBNP|258316‏
996 ‎‡2 J9U|987009747993605171‏
996 ‎‡2 ISNI|0000000110457950‏
996 ‎‡2 PTBNP|1572211‏
996 ‎‡2 RERO|A009093645‏
996 ‎‡2 PTBNP|66731‏
996 ‎‡2 NTA|108097137‏
996 ‎‡2 ISNI|0000000068614026‏
996 ‎‡2 ISNI|0000000069615098‏
996 ‎‡2 ISNI|0000000068113408‏
996 ‎‡2 PTBNP|230851‏
996 ‎‡2 N6I|vtls000080713‏
996 ‎‡2 PTBNP|1712193‏
996 ‎‡2 LC|nb2020008686‏
996 ‎‡2 ISNI|0000000419579200‏
996 ‎‡2 NTA|108242765‏
996 ‎‡2 PTBNP|210139‏
996 ‎‡2 PTBNP|51752‏
996 ‎‡2 BNF|12076254‏
996 ‎‡2 PTBNP|234523‏
996 ‎‡2 BIBSYS|90937239‏
996 ‎‡2 PTBNP|210522‏
996 ‎‡2 ISNI|0000000418120828‏
996 ‎‡2 ISNI|0000000121323587‏
996 ‎‡2 PTBNP|771052‏
996 ‎‡2 LC|n 82063719‏
996 ‎‡2 ISNI|0000000122092071‏
996 ‎‡2 PTBNP|285765‏
996 ‎‡2 NSK|000528571‏
996 ‎‡2 PTBNP|46320‏
996 ‎‡2 PTBNP|242785‏
996 ‎‡2 BLBNB|001416143‏
996 ‎‡2 NII|DA15220703‏
996 ‎‡2 SUDOC|031657885‏
996 ‎‡2 PTBNP|148787‏
996 ‎‡2 BNF|12283147‏
996 ‎‡2 PTBNP|51957‏
996 ‎‡2 ISNI|000000006849620X‏
996 ‎‡2 PTBNP|1756641‏
996 ‎‡2 BLBNB|000457310‏
996 ‎‡2 PTBNP|157380‏
996 ‎‡2 PTBNP|1878577‏
996 ‎‡2 NTA|135442052‏
996 ‎‡2 PTBNP|284517‏
996 ‎‡2 LC|no2022078503‏
996 ‎‡2 ISNI|0000000067651634‏
996 ‎‡2 ISNI|0000000373571202‏
996 ‎‡2 ISNI|0000000068704662‏
996 ‎‡2 NUKAT|n 2020030802‏
996 ‎‡2 ISNI|0000000080960183‏
996 ‎‡2 NTA|364161027‏
996 ‎‡2 PTBNP|1454935‏
996 ‎‡2 DNB|1057658596‏
996 ‎‡2 ISNI|000000006807412X‏
996 ‎‡2 PTBNP|70994‏
996 ‎‡2 PTBNP|1170669‏
996 ‎‡2 PTBNP|325643‏
996 ‎‡2 PTBNP|51658‏
996 ‎‡2 ISNI|0000000069315079‏
996 ‎‡2 SUDOC|030594391‏
996 ‎‡2 ISNI|0000000444135337‏
996 ‎‡2 PTBNP|257500‏
996 ‎‡2 ISNI|0000000070312940‏
996 ‎‡2 NKC|hka20181007305‏
996 ‎‡2 SUDOC|156882868‏
996 ‎‡2 SUDOC|146097890‏
996 ‎‡2 BLBNB|000343100‏
996 ‎‡2 ISNI|0000000070416758‏
996 ‎‡2 PTBNP|78206‏
996 ‎‡2 DNB|1157822347‏
996 ‎‡2 ISNI|0000000068496576‏
996 ‎‡2 ISNI|0000000036018991‏
996 ‎‡2 PTBNP|218182‏
996 ‎‡2 BNF|11886807‏
996 ‎‡2 DNB|1055442065‏
996 ‎‡2 NUKAT|n 2008123925‏
996 ‎‡2 PTBNP|218188‏
996 ‎‡2 ISNI|0000000389014531‏
996 ‎‡2 PTBNP|53495‏
996 ‎‡2 PTBNP|215822‏
996 ‎‡2 PTBNP|51662‏
996 ‎‡2 LC|no2007011368‏
996 ‎‡2 PTBNP|51665‏
996 ‎‡2 ISNI|0000000385409608‏
996 ‎‡2 PTBNP|51667‏
996 ‎‡2 PTBNP|51669‏
996 ‎‡2 PTBNP|69943‏
996 ‎‡2 BLBNB|000185479‏
996 ‎‡2 DNB|1165658291‏
996 ‎‡2 ISNI|000000011925755X‏
996 ‎‡2 ISNI|0000000070329064‏
996 ‎‡2 ISNI|0000000110698535‏
996 ‎‡2 ISNI|0000000069918283‏
996 ‎‡2 PTBNP|248070‏
996 ‎‡2 LC|n 2017029325‏
996 ‎‡2 LC|no2013114101‏
996 ‎‡2 ISNI|0000000083710980‏
996 ‎‡2 PTBNP|135500‏
996 ‎‡2 PTBNP|43952‏
996 ‎‡2 LC|n 2022253528‏
996 ‎‡2 DNB|132734596X‏
996 ‎‡2 PTBNP|1178701‏
996 ‎‡2 PTBNP|285520‏
996 ‎‡2 ISNI|0000000068103955‏
996 ‎‡2 NTA|22771816X‏
996 ‎‡2 SUDOC|147882923‏
996 ‎‡2 NTA|072570512‏
996 ‎‡2 PTBNP|146149‏
996 ‎‡2 ISNI|0000000445510506‏
996 ‎‡2 SUDOC|02665279X‏
996 ‎‡2 ISNI|0000000068497587‏
996 ‎‡2 ISNI|0000000069724139‏
996 ‎‡2 PTBNP|541606‏
996 ‎‡2 BLBNB|001464485‏
996 ‎‡2 CAOONL|ncf10685817‏
996 ‎‡2 PTBNP|281395‏
996 ‎‡2 PTBNP|167143‏
996 ‎‡2 PTBNP|284429‏
996 ‎‡2 PLWABN|9810633206205606‏
996 ‎‡2 ISNI|0000000069924018‏
996 ‎‡2 ISNI|0000000113956990‏
996 ‎‡2 PTBNP|155681‏
996 ‎‡2 ISNI|0000000373497831‏
996 ‎‡2 ISNI|0000000026541439‏
996 ‎‡2 ISNI|0000000069424216‏
996 ‎‡2 NUKAT|n 2015082302‏
996 ‎‡2 SUDOC|131945963‏
996 ‎‡2 ISNI|0000000069512056‏
996 ‎‡2 ISNI|0000000121207877‏
996 ‎‡2 SUDOC|250419653‏
996 ‎‡2 DNB|138738092‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏